Literature DB >> 19769931

Two novel ternary albendazole-cyclodextrin-polymer systems: dissolution, bioavailability and efficacy against Taenia crassiceps cysts.

Francisca Palomares-Alonso1, Cesar Rivas González, Ma Josefa Bernad-Bernad, María Dolores Castillo Montiel, Guadalupe Palencia Hernández, Iliana González-Hernández, Nelly Castro-Torres, Enrique Pinzón Estrada, Helgi Jung-Cook.   

Abstract

The effect of two water-soluble polymers: pectin and polyvinylpyrrolidone in combination with beta-cyclodextrin, on the dissolution, bioavailability and cysticidal efficacy of albendazole was evaluated using a commercial suspension as reference product. The dissolution of the albendazole-beta-cyclodextrin-pectin formulation was slow and incomplete (44.7%). No statistical differences in C(max) and AUC were found between this formulation and the reference. Also its cysticidal efficacy (33%) was similar to the reference (38%). The albendazole-beta-cyclodextrin-polyvinylpyrrolidone formulation exhibited the highest dissolution rate (78.5%) and its bioavailability was also significantly increased (2.3-fold). In addition, the cysticidal activity of this formulation (83%) was greater than a commercial suspension. Our results suggest that the ternary system of albendazole-beta-cyclodextrin-polyvinylpyrrolidone could be a potential alternative for the treatment of systemic helmintic diseases and it is worth to continue its preclinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769931     DOI: 10.1016/j.actatropica.2009.09.006

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  9 in total

1.  In vivo albendazole treatment of Taenia crassiceps cysticerci strain WFU: proliferation, damage, and recovery.

Authors:  R Zurabian; L Aguilar-Vega; E Terrones Vargas; M E Cervera Hernández; K Willms; S Ruíz-Velasco Acosta
Journal:  Parasitol Res       Date:  2013-09-05       Impact factor: 2.289

2.  Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.

Authors:  P A Pacheco; L N C Rodrigues; J F S Ferreira; A C P Gomes; C J Veríssimo; H Louvandini; R L D Costa; L M Katiki
Journal:  Parasitol Res       Date:  2018-01-11       Impact factor: 2.289

3.  Characterizations and bioactivities of abendazole sulfoxide-loaded thermo-sensitive hydrogel.

Authors:  Yi Feng; Fen Wang; Xue-Wei Zhang; Harshit Bhutani; Bin Ye
Journal:  Parasitol Res       Date:  2016-12-27       Impact factor: 2.289

4.  Scolicidal and apoptotic activities of albendazole sulfoxide and albendazole sulfoxide-loaded PLGA-PEG as a novel nanopolymeric particle against Echinococcus granulosus protoscoleces.

Authors:  Marziyeh Naseri; Abolfazl Akbarzadeh; Adel Spotin; Nagibeh Asl Rahnemaii Akbari; Mahmoud Mahami-Oskouei; Ehsan Ahmadpour
Journal:  Parasitol Res       Date:  2016-09-14       Impact factor: 2.289

5.  Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.

Authors:  Agustina García; Darío Leonardi; María D Vasconi; Lucila I Hinrichsen; María C Lamas
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

6.  Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.

Authors:  Krishna Pillai; Javed Akhter; David Lawson Morris
Journal:  J Cancer       Date:  2017-03-12       Impact factor: 4.207

7.  Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats.

Authors:  María Isabel Ruiz-Olmedo; Iliana González-Hernández; Francisca Palomares-Alonso; Javier Franco-Pérez; María de Lourdes González F; Helgi Jung-Cook
Journal:  Saudi Pharm J       Date:  2016-09-30       Impact factor: 4.330

8.  Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate.

Authors:  María Esperanza Adrover; Marisa Pedernera; Magali Bonne; Bénédicte Lebeau; Verónica Bucalá; Loreana Gallo
Journal:  Saudi Pharm J       Date:  2019-11-13       Impact factor: 4.330

9.  Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.

Authors:  Agustina García; Darío Leonardi; Mario Oscar Salazar; María Celina Lamas
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.